Impact of cancer immunotherapy on the kidneys

The purpose is to evaluate the impact of immunotherapy on the kidneys. The overall goal of this project is to provide clinicians with non-invasive acute kidney injury (AKI) biomarkers in patients who develop kidney injury while on Immune Checkpoint Inhibitor (ICI) therapy and to understand the impact of early acute kidney injury (AKI)/acute interstitial nephritis (AIN) and other predictors on long-term chronic kidney disease risk in cancer survivors. Patients can access the study survey here: https://yalesurvey.ca1.qualtrics.com/jfe/form/SV_09xx6hfw9evWeTY